Regulation of 11 beta-hydroxysteroid dehydrogenase in rat brain and cloning of the gene promoter region
dc.contributor.author
Moisan, Marie-Pierre
en
dc.date.accessioned
2018-01-31T11:23:20Z
dc.date.available
2018-01-31T11:23:20Z
dc.date.issued
1993
dc.description.abstract
en
dc.description.abstract
Adrenal corticosteroid hormones play diverse and important roles
in development and homeostasis. Their complex effects are predominantly
mediated by intracellular receptors, which are of two types;
mineralocorticoid (MR, type I) and glucocorticoid (GR, type II). MR bind
aldosterone and physiological glucocorticoids (Cortisol, corticosterone)
with equivalent high affinity in vitro, whereas GR show a low affinity for
aldosterone but bind physiological glucocorticoids and the synthetic
glucocorticoid dexamethasone with high affinity. In vivo, kidney MR
selectively bind aldosterone despite a hundred-fold molar excess of
circulating glucocorticoids. This selectivity is due to the high activity of
the enzyme 11ß-hydroxysteroid dehydrogenase (11ß-OHSD) which catalyses
the reversible conversion of physiological glucocorticoids to inactive
products, but does not metabolise aldosterone, thus preventing
glucocorticoid access to renal MR. This thesis describes firstly the
presence and subregional distribution of 11ß-OHSD in rat brain using
Northern analysis, in situ hybridisation, and an 11ß-OHSD activity assay.
The enzyme was not only found in aldosterone selective regions, such as
periventricular areas of the hypothalamus, but also in hippocampus
where corticosterone is the physiological ligand for MR, and, more
surprisingly, in cerebellum which contains very low levels of MR.
Therefore it was postulated that 11ß-OHSD might modulate glucocorticoid
access to both types of corticosteroid receptor in brain. Furthermore,
brain but not renal, 11ß-OHSD was up-regulated by chronic glucocorticoid
but not aldosterone administration, suggesting a role for the enzyme in
controlling long-term neuronal glucocorticoid exposure. The importance
of 11ß-OHSD in brain was further substantiated by the finding of high 11ß-OHSD mRNA levels and activity in rat brain subregions in the early
postnatal period, with regionally specific developmental patterns of
activity. The enzyme may play an important role in the developing brain
by protecting tissues from (or exposing them to) elevated corticosterone
levels. To understand the molecular mechanisms underlying tissuespecific and ontogenic regulation of 11ß-OHSD a rat genomic clone was
isolated and partially sequenced. Differential promoter usage of the gene
was demonstrated in kidney; three transcription start sites were detected
within one kilobase of 5' flanking region of the gene, using primer
extension and ribonuclease protection analyses. Corresponding
transcripts were detected on Northern blots of kidney, but not liver RNA,
using specific oligonucleotide probes. Sequence analysis revealed a
number of putative transcription factor binding sites. These findings
might explain, at least in part, tissue-specific differences in the regulation
of 11ß-OHSD mRNA and activity.
en
dc.identifier.uri
http://hdl.handle.net/1842/26785
dc.publisher
The University of Edinburgh
en
dc.relation.ispartof
Annexe Thesis Digitisation Project 2017 Block 15
en
dc.relation.isreferencedby
en
dc.title
Regulation of 11 beta-hydroxysteroid dehydrogenase in rat brain and cloning of the gene promoter region
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- MoisanMP_1993redux.pdf
- Size:
- 29.4 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

